SCHEMBL7183973

SCHEMBL7183973

CCC1CCC(c2ccc(O)cc2)(c2ccc(O)cc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 13/20 0.55
ESR1 P03372 9/20 0.55
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
GAA P10253 2/20 0.37
HPGD P15428 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
CYP3A4 P08684 3/20 0.35
CYP2C9 P11712 3/20 0.35
MEN1 O00255 2/20 0.35
GLA P06280 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP2D6 P10635 2/20 0.35
NPC1 O15118 1/20 0.35
NR1I2 O75469 1/20 0.35
GMNN O75496 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9353974 0.93 ESR2 (0.48) ESR2ESR1OPRD1OPRK1CYP3A4
SCHEMBL9353981 0.93 ESR2 (0.48) ESR2ESR1OPRD1OPRK1CYP3A4
SCHEMBL9348671 0.90 ESR2 (0.48) ESR2ESR1OPRD1OPRK1CYP3A4
SCHEMBL9348682 0.90 ESR2 (0.48) ESR2ESR1OPRD1OPRK1CYP3A4
SCHEMBL9348750 0.90 ESR2 (0.48) ESR2ESR1OPRD1OPRK1CYP3A4
SCHEMBL8021816 0.87 ESR2 (0.50) ESR2ESR1ALDH1A1OPRK1CYP2C9
SCHEMBL3302930 0.87 ESR2 (0.69) ESR2ESR1ALDH1A1OPRD1OPRK1
SCHEMBL17636592 0.86 ESR2 (0.57) ESR2ESR1CYP3A4CYP2C9CYP2D6
SCHEMBL9354045 0.84 ESR2 (0.47) ESR2ESR1ALDH1A1OPRD1OPRK1
SCHEMBL9354044 0.84 ESR2 (0.47) ESR2ESR1ALDH1A1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8840807-B2 Polymerizable compound JNC CORPORATION (JP) 2014-09-23 US disclosed
US-8840807-B2 Polymerizable compound JNC CORPORATION (JP) 2014-09-23 US disclosed
US-20130048912-A1 POLYMERIZABLE COMPOUND JNC PETROCHEMICAL CORPORATION (JP) 2013-02-28 US disclosed
US-20130048912-A1 POLYMERIZABLE COMPOUND JNC PETROCHEMICAL CORPORATION (JP) 2013-02-28 US disclosed
US-20030224222-A1 Aromatic polysulfone resin and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED 2003-12-04 US disclosed
EP-0469403-B1 High molecular weight polyester based on 1,1-bis-(4-hydroxyphenyl)-alkylcycloalkanes and thermoplastic blends thereof BAYER AG (DE) 1996-02-28 EP disclosed
EP-0368604-B1 New diamino and dinitro compounds and a process for preparing the diamino compounds CHISSO CORP (JP) 1994-08-31 EP disclosed
EP-0469404-A2 Polyestercarbonates based on 1,1-bis-(4-hydroxyphenyl)-alkylcycloalkanes and thermoplastic blends thereof BAYER AG (DE) 1992-02-05 EP disclosed
EP-0469403-A2 High molecular weight polyester based on 1,1-bis-(4-hydroxyphenyl)-alkylcycloalkanes and thermoplastic blends thereof BAYER AG (DE) 1992-02-05 EP disclosed
US-5008456-A Chemical intermediates for polyamides and polyimides CHISSO CORPORATION (JP) 1991-04-16 US disclosed
EP-0413190-A2 Polycarbonates prepared from n-alkyl substituted cyclohexylidene diphenols BAYER AG (DE) 1991-02-20 EP disclosed
EP-0368604-A2 New diamino and dinitro compounds and a process for preparing the diamino compounds CHISSO CORPORATION (JP) 1990-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048912-A1 POLYMERIZABLE COMPOUND PYM1, ZYX, CPNE4 ESR2 2691/4885ESR1 897/4885KDM4E 2083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.